The cost‐effectiveness of prophylaxis strategies for individuals with advanced HIV starting treatment in Africa

INTRODUCTION: Many HIV‐positive individuals in Africa have advanced disease when initiating antiretroviral therapy (ART) so have high risks of opportunistic infections and death. The REALITY trial found that an enhanced‐prophylaxis package including fluconazole reduced mortality by 27% in individual...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Simon M, Cox, Edward, Revill, Paul, Musiime, Victor, Bwakura‐Dangarembizi, Mutsa, Mallewa, Jane, Cheruiyot, Priscilla, Maitland, Kathryn, Ford, Nathan, Gibb, Diana M, Walker, A Sarah, Soares, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099175/
https://www.ncbi.nlm.nih.gov/pubmed/32219991
http://dx.doi.org/10.1002/jia2.25469

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7099175/
https://www.ncbi.nlm.nih.gov/pubmed/32219991
http://dx.doi.org/10.1002/jia2.25469

Ejemplares similares